• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Should Veeva’s Upgraded 2027 Outlook and Q2 Earnings Setup Require Action From Veeva Systems (VEEV) Investors?

    Simply Wall St·07/25/2026 07:27:47
    语音播报
    • In recent days, Veeva Systems prepared to report its fiscal Q2 2027 results after previously raising its fiscal 2027 guidance for revenue and adjusted earnings, drawing heightened analyst attention.
    • This combination of upgraded outlook and approaching earnings has highlighted the tension between generally optimistic brokerage views and more measured ratings that stress caution.
    • We’ll now examine how Veeva’s raised fiscal 2027 guidance, set against mixed analyst ratings, reshapes the company’s broader investment narrative.

    AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

    Veeva Systems Investment Narrative Recap

    To be a Veeva shareholder, you need to believe in its role as core infrastructure for life sciences software and data across R&D and commercial workflows. The raised fiscal 2027 guidance reinforces that thesis but does not fundamentally change the near term catalyst, which remains execution on AI driven Vault and Falcon rollouts, nor the key risk, which is intensifying competition from large platforms that could pressure CRM share and pricing.

    The most relevant recent announcement here is Veeva’s June guidance raise to US$3,635 million to US$3,645 million in fiscal 2027 revenue. That outlook sits against a stock that has lagged over one and five years, and analyst opinions that range from Moderate Buy to Hold, putting extra focus on whether upcoming earnings and early AI adoption data support this higher bar or revive concerns about slower growth and customer concentration.

    Yet behind the upbeat guidance, investors should be aware of growing pressure from large horizontal software rivals that could...

    Read the full narrative on Veeva Systems (it's free!)

    Veeva Systems' narrative projects $4.7 billion revenue and $1.4 billion earnings by 2029. This requires 12.4% yearly revenue growth and about a $458.3 million earnings increase from $941.7 million today.

    Uncover how Veeva Systems' forecasts yield a $245.48 fair value, a 32% upside to its current price.

    Exploring Other Perspectives

    VEEV 1-Year Stock Price Chart
    VEEV 1-Year Stock Price Chart

    Some of the lowest estimate analysts were already assuming only about 10.8 percent annual revenue growth and US$1.3 billion in earnings by 2029, so if you worry that rising AI competition could compress Veeva’s core CRM economics, their more cautious view may feel closer to home than the current guidance suggests.

    Explore 12 other fair value estimates on Veeva Systems - why the stock might be worth 11% less than the current price!

    The Verdict Is Yours

    Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

    • A great starting point for your Veeva Systems research is our analysis highlighting 3 key rewards that could impact your investment decision.
    • Our free Veeva Systems research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Veeva Systems' overall financial health at a glance.

    Interested In Other Possibilities?

    Our top stock finds are flying under the radar-for now. Get in early:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.